DrugPatentWatch Database Preview
Formulation information for generic ingredient: semaglutide
» See Plans and Pricing
Dulaglutide
CASRN: 923950-08-7
➤ Get the DrugPatentWatch Daily Briefing
Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …
Serving leading biopharmaceutical companies globally:
Last Updated: January 20, 2021
DrugPatentWatch Database Preview
CASRN: 923950-08-7
Serving leading biopharmaceutical companies globally: